DK312387A - Humane tumor tnf polypeptidmutanter, deres fremstilling og dna, kodende disse - Google Patents

Humane tumor tnf polypeptidmutanter, deres fremstilling og dna, kodende disse

Info

Publication number
DK312387A
DK312387A DK312387A DK312387A DK312387A DK 312387 A DK312387 A DK 312387A DK 312387 A DK312387 A DK 312387A DK 312387 A DK312387 A DK 312387A DK 312387 A DK312387 A DK 312387A
Authority
DK
Denmark
Prior art keywords
dna
polypeptime
mutants
coding
preparation
Prior art date
Application number
DK312387A
Other languages
Danish (da)
English (en)
Other versions
DK312387D0 (da
Inventor
Junichi Yamagishi
Hitoshi Kawashima
Ryuji Furuta
Hirotada Kontani
Katuhisa Nakata
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Publication of DK312387D0 publication Critical patent/DK312387D0/da
Publication of DK312387A publication Critical patent/DK312387A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
DK312387A 1986-06-20 1987-06-19 Humane tumor tnf polypeptidmutanter, deres fremstilling og dna, kodende disse DK312387A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14557586 1986-06-20

Publications (2)

Publication Number Publication Date
DK312387D0 DK312387D0 (da) 1987-06-19
DK312387A true DK312387A (da) 1987-12-21

Family

ID=15388278

Family Applications (1)

Application Number Title Priority Date Filing Date
DK312387A DK312387A (da) 1986-06-20 1987-06-19 Humane tumor tnf polypeptidmutanter, deres fremstilling og dna, kodende disse

Country Status (10)

Country Link
US (1) US4990455A (fr)
EP (1) EP0251037B1 (fr)
KR (1) KR880000471A (fr)
AT (1) ATE107362T1 (fr)
AU (1) AU592196B2 (fr)
DE (1) DE3750056T2 (fr)
DK (1) DK312387A (fr)
HU (1) HU210118B (fr)
PH (1) PH26714A (fr)
SU (1) SU1762761A3 (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0247906B1 (fr) * 1986-02-04 1994-12-28 Mizuno, Den'Ichi ADN codant pour des polypeptides antitumoraux, les polypeptides et les agents antitumoraux contenant ces polypeptides
DE3716513A1 (de) * 1987-05-16 1988-11-24 Basf Ag Proteine mit tnf-wirkung
DE3837012A1 (de) * 1988-01-15 1989-07-27 Knoll Ag Verwendung von tnf und lt zur herstellung von arzneimitteln
JPH0797997B2 (ja) * 1988-04-28 1995-10-25 帝人株式会社 新規生理活性ポリペプチド
DE3843534A1 (de) * 1988-12-23 1990-07-12 Basf Ag Neue tnf-polypeptide
DE3922089A1 (de) * 1989-05-09 1990-12-13 Basf Ag Neue proteine und ihre herstellung
US6262239B1 (en) 1989-05-18 2001-07-17 Yeda Research And Development Co., Ltd. TNF receptor-specific antibodies
US6232446B1 (en) 1989-05-18 2001-05-15 Yeda Research And Development Co. Ltd. TNF ligands
JP3203599B2 (ja) * 1989-10-24 2001-08-27 カイロン コーポレイション 感染性タンパク質デリバリーシステム
US5519119A (en) * 1990-09-21 1996-05-21 Ishihara Sangyo Kaisha Ltd. Muteins of TNF pharmaceutical compositions and a method of making
US5653974A (en) * 1990-10-18 1997-08-05 Board Of Regents,The University Of Texas System Preparation and characterization of liposomal formulations of tumor necrosis factor
CA2055168A1 (fr) * 1990-11-21 1992-05-22 Walter Fiers Muteines de tnf
KR970005042B1 (ko) * 1993-02-09 1997-04-11 한일합성섬유공업 주식회사 종양괴사인자-알파 뮤테인
CA2119089A1 (fr) * 1993-03-29 1994-09-30 David Banner Muteines du facteur de necrose tumoral
US5888814A (en) * 1994-06-06 1999-03-30 Chiron Corporation Recombinant host cells encoding TNF proteins
US6184344B1 (en) * 1995-05-04 2001-02-06 The Scripps Research Institute Synthesis of proteins by native chemical ligation
US7070771B1 (en) 1996-12-09 2006-07-04 Regents Of The University Of California Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells
SK285639B6 (sk) 1997-04-15 2007-05-03 Pharmexa A/S Modifikovaná ľudská TNFalfa molekula, DNA kódujúce takéto TNFalfa molekuly, spôsob výroby modifikovanej ľudskej TNFalfa molekuly, vakcíny obsahujúce modifikované TNFalfa molekuly a DNA a ich použitie
US7056695B2 (en) 2000-03-02 2006-06-06 Xencor TNF-α variants
US20070172449A1 (en) * 2000-03-02 2007-07-26 Xencor, Inc. TNF-alpha VARIANT FORMULATIONS FOR THE TREATMENT OF TNF-alpha RELATED DISORDERS
US7244823B2 (en) 2000-03-02 2007-07-17 Xencor TNF-alpha variants proteins for the treatment of TNF-alpha related disorders
US7101974B2 (en) 2000-03-02 2006-09-05 Xencor TNF-αvariants
US7662367B2 (en) 2000-03-02 2010-02-16 Xencor, Inc. Pharmaceutical compositions for the treatment of TNF-α related disorders
US7687461B2 (en) * 2000-03-02 2010-03-30 Xencor, Inc. Treatment of TNF-α related disorders with TNF-α variant proteins
US7446174B2 (en) 2001-03-02 2008-11-04 Xencor, Inc. Protein based TNF-α variants for the treatment of TNF-α related disorders
US7786282B2 (en) * 2001-12-06 2010-08-31 The Regents Of The University Of California Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain
KR100475403B1 (ko) * 2002-05-28 2005-03-15 재단법인서울대학교산학협력재단 반도체 배선용 구리 박막 형성방법
ES2347239T3 (es) * 2002-12-02 2010-10-27 Amgen Fremont Inc. Anticuerpos dirigidos al factor de necrosis tumoral y usos de los mismos.
EP3936137A1 (fr) 2013-02-07 2022-01-12 The General Hospital Corporation Procédés d'expansion ou de déplétion de lymphocytes t régulateurs

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3723249A (en) * 1970-02-21 1973-03-27 Ajinomoto Kk Method of producing l-arginine by microorganism
JPS6066989A (ja) * 1983-09-24 1985-04-17 Kyowa Hakko Kogyo Co Ltd Ｌ−アルギニンの製造法
DE3582183D1 (de) * 1984-03-06 1991-04-25 Dainippon Pharmaceutical Co Dns den menschlichen tumornekrosisfaktor kodierend und das menschliche tumornekronisfaktor-polypeptid.
GR851626B (fr) * 1984-07-05 1985-11-26 Genentech Inc
WO1986002381A1 (fr) * 1984-10-15 1986-04-24 Cetus Corporation Facteur de necrose de tumeurs humaines
EP0205038A1 (fr) * 1985-05-29 1986-12-17 Suntory Limited Polypeptide, son procédé de préparation, micro-organisme et utilisation pharmaceutique

Also Published As

Publication number Publication date
HU210118B (en) 1995-02-28
EP0251037A2 (fr) 1988-01-07
DK312387D0 (da) 1987-06-19
EP0251037B1 (fr) 1994-06-15
DE3750056T2 (de) 1995-04-06
PH26714A (en) 1992-09-15
SU1762761A3 (ru) 1992-09-15
DE3750056D1 (de) 1994-07-21
AU7450887A (en) 1988-01-07
HUT46065A (en) 1988-09-28
US4990455A (en) 1991-02-05
ATE107362T1 (de) 1994-07-15
KR880000471A (ko) 1988-03-26
EP0251037A3 (en) 1988-12-07
AU592196B2 (en) 1990-01-04

Similar Documents

Publication Publication Date Title
DK312387A (da) Humane tumor tnf polypeptidmutanter, deres fremstilling og dna, kodende disse
DZ467A1 (fr) Interferon immunitaire urbain.
ES8703490A1 (es) Un procedimiento para producir un polipeptido que tiene o contiene un polipeptido de factor de necrosis de tumor humano
HK1008823A1 (en) Antibodies to mammalian interleukin-4 and peptides useful as antigens in their production
DE3479321D1 (en) Biosynthetically produced human nerve growth factor, process for producing it, compositions containing it, dna sequence encoding it, vectors containing the sequence and host cells transformed thereby
HUT44615A (en) Process for preparing gm-cst protein and its derivatives
ES547436A0 (es) Un procedimiento para producir un adn complementario clonadoo su adn modificado que codifica un polipeptido de factor denecrosis de tumores
KR970009340B1 (en) Mutant acidic fibroblast growth factor
ATE194624T1 (de) Mutanten von menschlichem antithrombin iii
NO890174L (no) Rekombinante interleukin-1alfa-polypeptider.
PT89511A (pt) Processo para a preparacao de anfiregulina, um regulador bifuncional do crescimento de celulas

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment